In this episode of Tenzing's Executive Edge, Greg once again sits down with Dave Stowe, founder and managing partner of Adventus to explore the unique role procurement plays in the life sciences industry. Dave explains why procurement in biotech and pharma operates under a different set of pressures than most industries, where supplier decisions, contract structures, and cost management can directly impact the success or failure of clinical trials and emerging therapies.

Greg and Dave walk through the drug development lifecycle from discovery and preclinical testing to the three phases of clinical trials, highlighting how procurement teams can better support scientific stakeholders, manage Contract Research Organization (CRO) relationships, and create the financial discipline needed to bring innovative treatments to market.

Whether you're in procurement, operations, or life sciences leadership, this conversation offers practical insights into navigating one of the most complex and high-stakes sourcing environments in business.